Asia Pacific Buprofezin Market Size & Outlook, 2026-2034


Asia Pacific Buprofezin Market Insights

  • As highlighted in Reed Intelligence analysis, the Asia Pacific Buprofezin Market, valued at USD 165.02 Million in 2025, is estimated to achieve USD 262.88 Million by 2034.
  • The market is estimated to grow at a CAGR of 5.32% spanning 2026 to 2034.
  • By market size, Suspension Concentrate led the By Formulation Type category in 2025.
  • The By Formulation Type segment led by Wettable Powder is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.

Other Key Findings


  • In 2025, Asia Pacific contributed 35.26% to the overall global Buprofezin Market size.
  • By 2034, United States is anticipated to dominate the global market based on market size.
  • Japan is expected to witness the fastest growth within Asia Pacific, attaining USD 39.43 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 165.02 Million
Market Size In 2034 USD 262.88 Million
Largest segment Suspension Concentrate
Units Revenue in USD Million
CAGR 5.32% (2026-2034)
Segmnetation Covered
Asia Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Taiwan
  6. Australia
  7. Singapore
  8. South East Asia
By Formulation Type
  1. Suspension Concentrate
  2. Wettable Powder
  3. Emulsifiable Concentrate
  4. Water Dispersible Granules
By Crop Type
  1. Rice
  2. Cotton
  3. Vegetables
  4. Fruits
By Application Method
  1. Foliar Spraying
  2. Soil Application
  3. Seed Treatment
By Distribution Channel
  1. Agrochemical Distributors
  2. Agricultural Cooperatives
  3. Retail Agricultural Stores
  4. Online Agricultural Platforms
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends